David B. Bartlett

Reducing the Burden of Hypoglycemia in Type 1 Diabetes: The Impact of FLO23011 on Patient-Reported Outcomes and Glycemic Correlates of Treatment Response

Abstract Objective To compare patient-reported outcomes (PROs) for hypoglycemia recovery with FLO23011, a glucose/beta-hydroxybutyrate Multi-Energy Substrate for Hypoglycemia (MESH) treatment, versus standard glucose gel in type 1 diabetes, contextualized by continuous glucose mo...